Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2013 082 774.5 |
96 | EP file number | EAKZ | 19 19 2142.8 |
97 | EP publication number | EPN | 3632919 |
54 | Designation/title | TI | PHARMAZEUTISCHE ZUSAMMENSETUNGEN ENTHALTEND IMIDAZOTHIADIAZOL- UND IMIDAZOPYRIDAZINDERIVATE ALS PROTEASEAKTIVIERTE REZEPTOR 4 (PAR4)-INHIBITOREN ZUR BEHANDLUNG VON THROMBOZYTENAGGREGATION |
51 | IPC main class | ICM (ICMV) | C07D 519/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/433 (2006.01), C07D 513/04 (2006.01), A61K 31/5025 (2006.01), C07D 487/04 (2006.01), A61K 31/4355 (2006.01), A61P 7/02 (2006.01) |
22 | DE application date | DAT | Apr 24, 2013 |
96 | EP application date | EAT | Apr 24, 2013 |
43 | Date of first publication | OT | Apr 8, 2020 |
| Date of publication of grant | PET | Oct 26, 2022 |
71/73 | Applicant/owner | INH | Bristol-Myers Squibb Company, Princeton, US; Université de Montréal, Montréal, QC, CA |
72 | Inventor | IN | BANVILLE, Jacques, Montréal, Québec H3T 1J4, CA; RÉMILLARD, Roger, Napierville, Québec J0J 1L0, CA; RUEDIGER, Edward H., Montréal, Québec H3T 1J4, CA; DEON, Daniel H., Montréal, Québec H3T 1J4, CA; GAGNON, Marc, Montréal, Québec H3T 1J4, CA; DUBÉ, Laurence, Montréal, Québec H3T 1J4, CA; GUY, Julia, Montréal, Québec H3T 1J4, CA; PRIESTLEY, Eldon Scott, Pennington, NJ 08534, US; POSY, Shoshana L., Pennington, NJ 08543, US; MAXWELL, Brad D., Pennington, NJ 08543, US; WONG, Pancras C., Pennington, NJ 08534, US; LAWRENCE, Michael R., Pennington, NJ 08534, US; MILLER, Michael M., Princeton, NJ 08543, US |
| Address for service | | Marks & Clerk LLP, 1017 Luxembourg, LU |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361787680 P Mar 15, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261638577 P Apr 26, 2012
|
| Due date | FT FG | Apr 30, 2025 Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003632919A1 Searchable text:
EP000003632919A1 Original document:
EP000003632919B1 Searchable text:
EP000003632919B1 |
43 | Date of first publication | EVT | Apr 8, 2020 |
| Date of the first transfer into DPMAregister | EREGT | Apr 8, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | May 8, 2024 (Show all update days)(Hide all update days)- May 8, 2024; Mar 13, 2024; Oct 19, 2023; Sep 14, 2023; Mar 9, 2023; Nov 9, 2022; Oct 6, 2022; May 19, 2022
- Historical data not available for this/these date(s)
- Apr 8, 2020
- Date of the first transfer into DPMAregister
|